Journal
TRENDS IN MICROBIOLOGY
Volume 16, Issue 12, Pages 561-566Publisher
ELSEVIER SCI LTD
DOI: 10.1016/j.tim.2008.09.001
Keywords
-
Categories
Funding
- Australian National Health and Medical Research Council
- James S McDonnell Foundation
- Sylvia and Charles Viertel Senior Medical Research
Ask authors/readers for more resources
HIV-1 mutates extensively in vivo to escape immune control by CD8+ T cells (CTLs). The CTL escape mutant virus might also revert back to wild-type upon transmission to new hosts if significant fitness costs are incurred by the mutation. Immune escape and reversion can be extremely fast if they occur very early after infection, whereas they are much slower when they begin later during infection. Immune escape presents a significant barrier to vaccination, because escape of vaccine-mediated immune responses could neutralise any benefits of vaccination. Here, we consider the dynamics of immune escape and reversion in vivo in natural infection, and suggest how understanding of this can be used to predict optimal vaccine targets and design vaccination strategies that maximise immune control. We predict that inducing synchronous, broad CTL by vaccination should limit the likelihood of viral escape from immune control.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available